Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON

I Leader della Finanza

Ultime notizieSocietÓMercatiEconomia & ForexMaterie PrimeTassiLeader della FinanzaPro. della FinanzaAgendaSettori 
HomeTutte le notizieLe notizie pi¨ letteBiografie dei Leader della finanza
Portrait de Geoffrey von Maltzahn
EtÓ : 39
Patrimonio pubblico : 39 439 455 USD
Principali societÓ : Kaleido Biosciences, Inc.
Riassunto 
Founder of 8 different companies, including: Seres Therapeutics, Inc., Kaleido Biosciences, Inc. and Axcella Health, Inc. Geoffrey von Maltzahn and currently holds the position of Chief Executive Officer & Director at Tessera Therapeutics, Inc. (which he founded), Chief Innovation Officer & Director at Indigo Ag, Inc. (which he founded in 2013) and General Partner for Flagship Pioneering.

He is also on the board of Kaleido Biosciences, Inc. (former Chief Executive Officer) and Generate Biomedicines, Inc. (former Co-Chief Executive Officer).

Geoffrey von Maltzahn previously held the position of Chief Technology Officer at Seres Therapeutics, Inc. (he founded the company in 2010), Vice President-Discovery at Axcella Health, Inc. (he founded the company in 2008) and Vice President-Corporate Development for Essentient, Inc. (a subsidiary of Axcella Health, Inc.) and President, Chief Executive Officer & Director at Cobalt Biomedicine, Inc.

Dr. Von Maltzahn received a doctorate and an undergraduate degree from Massachusetts Institute of Technology and a graduate degree from the University of California San Diego.


Posti e reponsabilitÓ di Geoffrey von Maltzahn 
NomeTitolo Da
Kaleido Biosciences, Inc.
(Biotecnologia)
Director 2017
Indigo Ag, Inc. Chief Innovation Officer & Director -
Tessera Therapeutics, Inc. Chief Executive Officer & Director -
Generate Biomedicines, Inc. Director 2018
Flagship Pioneering General Partner -
Resonance Therapeutics Founder -


Participazioni di Geoffrey von Maltzahn 
NomeAzioni%Valorizzazione
Sana Biotechnology, Inc. (SANA)
(Biotecnologia)
1 830 6100,97%37 966 851 USD
Kaleido Biosciences, Inc. (KLDO)
(Biotecnologia)
342 4660,80%1 472 604 USD


Geoffrey von Maltzahn: network personale 
Le notizie pi¨ lette 
06/12MUKESH AMBANI: I venditori indiani minacciano interruzioni di fornitura per protestare contro Reliance
MR
30/11JACK DORSEY: Jack Dorsey insegue cripto, fintech sogno post Twitter
MR
01/12JACK DORSEY: Square, guidata da Dorsey, si ribattezza in Block in un cenno alla blockchain
MR
01/12Salesforce nomina Bret Taylor co-CEO, la previsione delle entrate delude
MR
03/12TILMAN FERTITTA: FAST Acquisition rifiuta di terminare la fusione SPAC con Fertitta Entertainment
MR
29/11ANIL AMBANI: La banca centrale dell'India avvia la procedura di fallimento contro Reliance Capital; co per conformarsi
MR
29/11JACK DORSEY: Twitter, si dimette Ceo Jack Dorsey
RE
01/12CARLOS TAVARES: Stellantis, per AD Tavares costo elettrificazione "oltre i limiti"
RE
06/12ANDREA ORCEL: UniCredit, Orcel si impegna ad aprire nuovo capitolo redditizio con nuovo piano
RE
25/11FRANCESCO GAETANO CALTAGIRONE: Generali, Caltagirone costituisce pegno su 0,6%, acquista altro 0,1%
RE
Pi¨ notizie


© 2021 People and Ownership :   
Geoffrey von Maltzahn : connessioni